Counterpart Health names Vicky Bruner as VP of operations

WILMINGTON, Del. - Counterpart Health, a subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV), appointed Vicky Bruner as Vice President of Operations, according to a press release issued Tuesday. The appointment comes as Clover Health, currently valued at $1.47 billion, shows strong momentum with a 69% return over the past year. According to InvestingPro analysis, the company maintains a GREAT financial health score, suggesting solid operational foundations.

In her new role, Bruner will oversee customer implementations, provider network engagement, clinician onboarding and training, and account support as the company expands its AI-powered physician-enablement platform.

Bruner previously served as Vice President of Network Performance at Optum Care Network, where she managed risk operations across five health plans in Washington and Oregon, focusing on quality performance and cost management for Medicare and Medicaid populations.

"Her experience building and optimizing systems for efficient service delivery, spearheading provider engagement with new products and services, and driving business outcomes will be invaluable as we continue to expand Counterpart’s footprint," said Conrad Wai, CEO of Counterpart.

The company’s main product, Counterpart Assistant, provides clinical insights to primary care providers at the point of care. The technology was initially developed as Clover Assistant within Clover Health before being extended to serve providers outside of Clover’s Medicare Advantage plan.

Counterpart Health aims to use its AI technology to reduce administrative work for clinicians while improving patient outcomes and reducing healthcare costs, according to the company statement.

In other recent news, Clover Health Investments Corp reported impressive financial results for the first quarter of 2025, with a notable 33% increase in revenue, reaching $457 million. The company also experienced a 30% growth in its Medicare Advantage membership. These developments reflect a strong start to the year and have led to an optimistic financial outlook, with the company raising its guidance for the full year 2025. Additionally, Clover Health has demonstrated its commitment to transparency by addressing shareholder queries. The company published responses to selected questions from shareholders, which are now accessible on its investor relations website and filed with the SEC. In personnel news, Clover Health appointed Joseph Oldakowski as Vice President of Finance and Controller. Oldakowski, who joined in June, will oversee corporate accounting, financial reporting, and tax functions, reporting directly to the Chief Financial Officer, Peter Kuipers. These recent developments highlight Clover Health’s proactive approach in both financial performance and corporate governance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.